UroGen Pharma Ltd. - Demonstração de Resultados (TTM)

UroGen Pharma Ltd.
DE ˙ DB ˙ IL0011407140
€ 22,57 ↓ -1.02 (-4.32%)
2026-06-02
PREÇO DA AÇÃO
Demonstração de Resultados (TTM)

A Demonstração de Resultados de UroGen Pharma Ltd. mostra mudanças na receita e despesas ao longo de um período de tempo. Os dados da Demonstração de Resultados incluem Vendas e Receita, Lucro Bruto, Pesquisa e Desenvolvimento (P&D), Despesas de Vendas, Gerais e Administrativas (SG&A), Renda Operacional, Despesa com Imposto de Renda, Despesa com Juros, Renda Não Operacional, Lucro por Ação (EPS) e Ações em Circulação.

Todos os números são vezes 1,000,000 exceto unidades por ação.

2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
2025
09-30
2025
12-31
2026
03-31
Receita 32 40 48 54 58 62 64 68 73 77 83 84 85 89 90 92 94 97 110 140
Mudar (%) 24.70 20.61 12.65 6.60 8.23 3.07 5.64 6.67 6.56 7.04 1.92 0.84 5.12 1.16 1.63 2.58 2.42 13.75 27.97
% da receita 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Custo das vendas 3 4 5 6 6 7 8 8 9 9 9 9 9 9 9 9 11 12 12 14
Mudar (%) 28.46 22.20 12.18 7.24 12.51 9.66 9.67 7.11 3.86 0.25 -5.74 -2.43 1.00 2.13 6.78 13.93 7.64 7.03 14.53
% da receita 10.28 10.59 10.73 10.69 10.75 11.18 11.89 12.35 12.40 12.08 11.32 10.47 10.13 9.73 9.82 10.32 11.46 12.05 11.34 10.15
Lucro Operacional Bruto 29 36 43 48 51 55 57 60 64 68 73 75 76 81 82 82 83 85 97 126
Mudar (%) 24.27 20.42 12.71 6.52 7.71 2.24 5.09 6.61 6.94 7.97 2.90 1.22 5.58 1.05 1.07 1.27 1.74 14.67 29.69
% da receita 89.72 89.41 89.27 89.31 89.25 88.82 88.11 87.65 87.60 87.92 88.68 89.53 89.87 90.27 90.18 89.68 88.54 87.95 88.66 89.85
Vendas, Gerais e Administrativas 89 88 88 87 85 83 83 86 88 90 93 96 104 111 120 128 141 150 155 172
Mudar (%) -0.50 -0.84 -1.02 -1.70 -3.00 0.26 3.83 1.93 3.06 3.23 3.03 7.87 6.93 8.31 6.39 10.29 6.13 3.74 10.65
% da receita 277.74 221.62 182.21 160.10 147.63 132.32 128.72 126.52 120.89 116.93 112.77 113.99 121.94 124.04 132.81 139.02 149.48 154.90 141.27 122.15
P&D 45 47 48 50 50 52 53 53 52 49 46 49 52 54 57 62 65 68 67 63
Mudar (%) 3.78 1.44 4.58 1.04 2.32 2.71 -0.37 -2.00 -5.54 -6.51 6.57 7.85 2.15 6.71 7.66 5.71 4.08 -0.86 -6.37
% da receita 141.66 117.90 99.17 92.06 87.26 82.50 82.21 77.53 71.22 63.14 55.15 57.66 61.67 59.93 63.21 66.97 69.01 70.13 61.12 44.72
OpEx 137 139 140 142 142 141 143 147 148 148 148 154 165 173 186 199 217 229 235 249
Mudar (%) 1.61 0.62 1.37 -0.38 -0.43 1.62 2.59 0.82 0.11 -0.16 3.56 7.27 5.10 7.50 6.80 9.05 5.59 2.55 5.99
% da receita 429.69 350.12 292.11 262.85 245.65 226.00 222.82 216.39 204.52 192.15 179.23 182.12 193.74 193.70 205.85 216.31 229.95 237.08 213.73 177.02
Lucro operacional -105 -100 -92 -88 -84 -79 -79 -79 -76 -71 -66 -69 -80 -84 -96 -107 -122 -132 -125 -108
Mudar (%) -5.40 -7.37 -4.50 -4.66 -6.37 0.47 0.11 -4.21 -6.05 -7.97 5.64 15.10 5.08 14.27 11.68 14.61 8.04 -5.63 -13.34
% da receita -329.69 -250.12 -192.11 -162.85 -145.65 -126.00 -122.82 -116.39 -104.52 -92.15 -79.23 -82.12 -93.74 -93.70 -105.85 -116.31 -129.95 -137.08 -113.73 -77.02
Despesa com juros -0 -3 -5 -8 -12 -13 -14 -15 -14 -13 -12 -13 -14 -15 -15 -15 -15
Mudar (%) 793.97 106.86 61.80 38.77 13.00 8.47 2.53 -7.52 -2.20 -8.22 2.51 12.95 4.74 4.40 -0.78 0.76
% da receita -0.52 -4.37 -8.35 -13.11 -17.22 -18.24 -18.57 -17.79 -16.14 -15.66 -13.67 -13.85 -15.39 -15.72 -16.02 -13.98 -11.01
Resultado líquido -111 -113 -111 -113 -114 -109 -110 -112 -109 -105 -102 -104 -114 -115 -127 -138 -155 -165 -153 -133
Mudar (%) 1.25 -1.84 2.22 0.41 -3.85 0.38 1.66 -2.29 -3.62 -2.71 2.03 8.88 1.58 9.96 9.11 11.95 6.24 -6.77 -13.21
% da receita -349.05 -283.41 -230.67 -209.30 -197.16 -175.16 -170.58 -164.16 -150.37 -136.00 -123.61 -123.74 -133.61 -129.11 -140.35 -150.68 -164.44 -170.59 -139.81 -94.83

Source: Capital IQ

How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
GB:0XOD US$ 28,31
US:URGN US$ 26,79
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista